US pharma giant Pfizer will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 ...

Chicago-based pharma major AbbVie and privately-held San Diego biotech ADARx Pharmaceuticals have announced a collaboration ...

US President Donald Trump released an executive order on May 12 calling for a 30-day negotiation period between the ...

Fibrosis drug developer Tvardi Therapeutics has hit the ground running after completing its merger with troubled US biotech ...

UK-based Kaerus Bioscience, a biopharma created by European investment firm Medicxi for the development of therapeutics for ...

In a further bid to expand its already lucrative portfolio of metabolic and obesity medicines, Denmark’s Novo Nordisk (NOV: N ...

US biotech Cytokinetics has unveiled fresh Phase III data backing its heart drug aficamten, showing the treatment was more ...

San Diego, USA-based biotech Capricor Therapeutics (Nasdaq; CAPR) yesterday announced the appointment of Dr Michael Binks as ...

Cambridge, USA-based biotech Stylus Medicine, which says it is dedicated to developing transformative in vivo genetic ...

Finnish biotech Tilt Biotherapeutics has raised $26 million (22.6 million euros) in a series B round to move its lead cancer ...

Danish CNS specialist Lundbeck (LUND: CO) today released first-quarter 2025 financials, along with a raised guidance for the ...

Belgian biotech Galapagos (Euronext: GLPG) is pausing its high-profile plan to break into two separate businesses, just five ...